Clinical Trials Browser

Phase 3 × Terminated × Melphalan × Clear all

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02489500 2018-09-10

VelRand

Phase 3 Terminated

3 enrolled 11 charts

Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT02366663 2018-03-12

SPINOZA

Phase 3 Terminated

3 enrolled 8 charts

Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00920153 2016-09-16

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

Phase 3 Terminated

442 enrolled

Lymphoid

Hodgkin Disease, Lymphoma

NCT00573391 2011-08-12

Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2

Phase 3 Terminated

5 enrolled 6 charts

Plasma cell

Multiple Myeloma

NCT00644306 2008-03-26

IFM 01/01

Phase 3 Terminated

232 enrolled

Plasma cell

Multiple Myeloma

Clinical Trials

BMT CTN 0901

VelRand

SPINOZA

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2

IFM 01/01